Literature DB >> 19558398

The stability of error-related brain activity with increasing trials.

Doreen M Olvet1, Greg Hajcak.   

Abstract

The error-related negativity (ERN) and error positivity (Pe) are increasingly being examined as neural correlates of response monitoring. The minimum number of error trials included in grand averages varies across studies; indeed, there has not been a systematic investigation on the number of trials required to obtain a stable ERN and Pe. In the current study, the ERN and Pe were quantified as two random trials were added to participants' (N=53) ERP averages. Adding trials increased the correlation with the grand average ERN and Pe; however, high correlations (rs>.80) were obtained with only 6 trials. Internal reliability of the ERN and Pe reached moderate levels after 6 and 2 trials and the signal-to-noise ratio of the ERN and Pe did not change after 8 and 4 trials, respectively. Combined, these data suggest that the ERN and Pe can be quantified using a minimum of between 6 and 8 error trials.

Entities:  

Mesh:

Year:  2009        PMID: 19558398     DOI: 10.1111/j.1469-8986.2009.00848.x

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  140 in total

1.  Meditation, mindfulness and executive control: the importance of emotional acceptance and brain-based performance monitoring.

Authors:  Rimma Teper; Michael Inzlicht
Journal:  Soc Cogn Affect Neurosci       Date:  2012-04-15       Impact factor: 3.436

2.  The development of the error-related negativity (ERN) and its relationship with anxiety: evidence from 8 to 13 year-olds.

Authors:  Alexandria Meyer; Anna Weinberg; Daniel N Klein; Greg Hajcak
Journal:  Dev Cogn Neurosci       Date:  2012-01       Impact factor: 6.464

3.  Error-related processing in adult males with elevated psychopathic traits.

Authors:  Vaughn R Steele; J Michael Maurer; Edward M Bernat; Vince D Calhoun; Kent A Kiehl
Journal:  Personal Disord       Date:  2015-10-19

4.  Error monitoring dysfunction across the illness course of schizophrenia.

Authors:  Veronica B Perez; Judith M Ford; Brian J Roach; Scott W Woods; Thomas H McGlashan; Vinod H Srihari; Rachel L Loewy; Sophia Vinogradov; Daniel H Mathalon
Journal:  J Abnorm Psychol       Date:  2011-11-07

5.  Electrocortical and behavioral measures of response monitoring in young children during a Go/No-Go task.

Authors:  Dana C Torpey; Greg Hajcak; Jiyon Kim; Autumn Kujawa; Daniel N Klein
Journal:  Dev Psychobiol       Date:  2011-08-03       Impact factor: 3.038

6.  Attention bias modification reduces neural correlates of response monitoring.

Authors:  Brady D Nelson; Felicia Jackson; Nader Amir; Greg Hajcak
Journal:  Biol Psychol       Date:  2017-09-01       Impact factor: 3.251

7.  Reward processing deficits and impulsivity in high-risk offspring of alcoholics: A study of event-related potentials during a monetary gambling task.

Authors:  Chella Kamarajan; Ashwini K Pandey; David B Chorlian; Niklas Manz; Arthur T Stimus; Lance O Bauer; Victor M Hesselbrock; Marc A Schuckit; Samuel Kuperman; John Kramer; Bernice Porjesz
Journal:  Int J Psychophysiol       Date:  2015-09-18       Impact factor: 2.997

8.  The acute effects of MDMA and ethanol administration on electrophysiological correlates of performance monitoring in healthy volunteers.

Authors:  D B Spronk; G J H Dumont; R J Verkes; E R A De Bruijn
Journal:  Psychopharmacology (Berl)       Date:  2014-04-26       Impact factor: 4.530

9.  Effects of reward context on feedback processing as indexed by time-frequency analysis.

Authors:  Adreanna T M Watts; Edward M Bernat
Journal:  Psychophysiology       Date:  2018-05-11       Impact factor: 4.016

10.  Neural Biomarker and Early Temperament Predict Increased Internalizing Symptoms After a Natural Disaster.

Authors:  Alexandria Meyer; Carla Kmett Danielson; Allison P Danzig; Vickie Bhatia; Sarah R Black; Evelyn Bromet; Gabrielle Carlson; Greg Hajcak; Roman Kotov; Daniel N Klein
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2017-03-06       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.